Item 8.01           Other Events.

On January 14, 2020, BioSig Technologies, Inc. (the "Company") issued a press release announcing that the Company has been awarded a fifth utility patent covering its PURE EP™ System. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.

On January 16, 2020, the Company issued a press release announcing that it installed its PURE EP™ System at Mayo Clinic in Florida (the "Clinic") to conduct patient cases under the Company's clinical trial titled "Novel Cardiac Signal Processing System for Electrophysiology Procedures (PURE EP 2.0 Study)." A copy of the press release is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.




Item 9.01       Financial Statements and Exhibits.



(d) Exhibits



Exhibit Number   Description
99.1               Press Release, dated January 14, 2020
99.2               Press Release, dated January 16, 2020

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses